More Globe Newswire

View Older Stories View Newer Stories

Mar 4, 2024 04:49AM Transactions in connection with share buyback programme
Mar 4, 2024 04:44AM Havila Shipping ASA: Extended contracts for Havila Borg and Havila Fanø
Mar 4, 2024 04:29AM Transactions in connection with share buy-back program
Mar 4, 2024 04:30AM SHARE BUYBACK TRANSACTIONS
Mar 4, 2024 04:26AM Disclosure of total number of voting rights and number of shares in the capital at January 31, 2024
Mar 4, 2024 04:00AM Fusion Fuel Receives €1 Million Grant from European Innovation Fund for Alentejo Green Hydrogen Valley through H2tALENT Consortium
Mar 4, 2024 04:00AM FLYR for Hospitality Now Available on Oracle Cloud Marketplace
Mar 4, 2024 04:00AM Gordon Brothers Offering for Sale by Private Treaty Royal Falcon One Superyacht
Mar 4, 2024 03:59AM Prepayments (CK93) - Totalkredit A/S
Mar 4, 2024 04:00AM Danske Bank share buy-back programme: Transactions in week 9
Mar 4, 2024 04:00AM Notice of Annual General Meeting 2024
Mar 4, 2024 03:58AM Landsbankinn hf.: Tender offer
Mar 4, 2024 03:54AM Prepayments (CK93) - Nykredit Realkredit A/S
Mar 4, 2024 03:46AM 15/2024・Trifork Holding AG – Weekly report on share buyback
Mar 4, 2024 03:42AM Share buy-back programme - week 9
Mar 4, 2024 03:30AM Alm. Brand A/S – Weekly report on share buybacks
Mar 4, 2024 03:00AM SHR and Cloudbeds partner to transform hospitality management
Mar 4, 2024 02:58AM Preliminary data on early redemptions (prepayments)
Mar 4, 2024 02:57AM Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for February 2024 of its Virtune Crypto Top 10 Index ETP, the first crypto index ETP in the Nordics
Mar 4, 2024 02:54AM Form 8.5 (EPT/RI) - musicMagpie Plc
Mar 4, 2024 02:53AM Articles of Association for Ringkjøbing Landbobank A/S
Mar 4, 2024 02:30AM BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
Mar 4, 2024 02:21AM Form 8.5 (EPT/RI) - Abrdn European Logistics Income Plc
Mar 4, 2024 02:15AM Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary)
Mar 4, 2024 02:05AM BNP Paribas launches a share buyback programme of EUR 1.055 billion
Mar 4, 2024 02:00AM Cornish Metals to Bring Forward Refurbishment of New Cook’s Kitchen Shaft
Mar 4, 2024 02:00AM Galantas Gold Announces Sampling Program for Gairloch Gold-Bearing VMS Project in Scotland, in Collaboration With University of Edinburgh
Mar 4, 2024 02:00AM VAALCO Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
Mar 4, 2024 02:00AM Caledonia Mining Corporation Plc Trading update for the year ended December 31, 2023
Mar 4, 2024 02:00AM Andrew Fisher Joins Verona Pharma as General Counsel
Mar 4, 2024 02:00AM Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo
Mar 4, 2024 02:00AM ING to repurchase shares for employee compensation
Mar 4, 2024 02:00AM Subsea 7 share repurchases
Mar 4, 2024 02:00AM Dividend payment ex-date of Arco Vara AS
Mar 4, 2024 01:45AM South Korea has granted Lleida.net its sixth patent in the country
Mar 4, 2024 01:32AM BioVie Inc. Announces Pricing of Public Offering
Mar 4, 2024 01:30AM Transaction in Own Shares
Mar 4, 2024 01:30AM BGHL (EUR): NAV(s)
Mar 4, 2024 01:30AM BGHL (EUR): NAV(s)
Mar 4, 2024 01:30AM BGHL (GBP): NAV(s)
Mar 4, 2024 01:30AM BW Offshore: Ex dividend USD 0.088 today
Mar 4, 2024 01:36AM
Mar 4, 2024 01:36AM
Mar 4, 2024 01:15AM Novartis presents new data on safety and efficacy of Zolgensma, including maintained and improved motor milestones in older and heavier children with SMA
Mar 4, 2024 01:15AM Novartis presents new data on safety and efficacy of Zolgensma, including maintained and improved motor milestones in older and heavier children with SMA
Mar 4, 2024 01:27AM Virtualware appoints a new USA operations president, John A. Cunningham, to lead the company's growth in the American market
Mar 4, 2024 01:00AM Coherus Completes Divestiture of Ophthalmology Franchise
Mar 4, 2024 01:00AM Start of Day Message
Mar 4, 2024 01:00AM Sandoz acquires CIMERLI® business from Coherus, further building biosimilar and ophthalmology leadership in US market
Mar 4, 2024 01:00AM Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease
View Newer Stories View Older Stories